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Abstract 
Administration of empirical antibiotic therapy prior to microbiological diagnosis is thought to be associated the failure 
of subsequent bacterial growth in culture. The aim of this study was to detect bacterial pathogens via direct ampli‑
fication and sequencing of the 16S rDNA gene in samples showing negative culture results as alternative diagnostic 
tools to troubleshoot difficult samples. Twenty‑three (7.66 %) positive samples were detected, most of which were 
monomicrobial infections; 15 of the cases were identified as HAIs, 6 had catheter colonisation, and 2 had sample 
colonisation. The pathogens identified included Escherichia, Salmonella, Pseudomonas spp., Enterococcus spp. and 
coagulase‑negative staphylococci (CoNS). The most frequent infections were bacteraemia and urinary tract infection, 
but meningitis, warm infection and soft tissue infection were also documented. These findings emphasise the efficacy 
and usefulness of molecular diagnosis, thus 16S rDNA gene analysis is strongly indicated by HAIs diagnostics.
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Background
Over the last two decades, broad-range polymerase chain 
reaction (PCR) analysis of bacterial 16S rDNA genes has 
proven to be a useful tool, not only to establish phyloge-
netic bacterial relationships but also to identify unchar-
acterised bacterial isolates, as well as bacterial pathogens, 
directly from clinical specimens (Petti 2007). Bacterial 
16S rDNA genes generally contain nine “hypervariable 
regions” that demonstrate considerable sequence diver-
sity among different bacterial species. These regions are 
flanked by conserved stretches in most bacteria, ena-
bling PCR amplification of target sequences using uni-
versal primers (Chakravorty et  al. 2007). Diverse sets of 
broad-range PCR primers directed against conserved 
regions of the 16S rDNA gene have been designed to spe-
cifically amplify several bacterial genera (e.g., the V1-V3 
region) (Chakravorty et al. 2007; Clarridge III 2004; Nik-
kari et al. 2002); universal primers are typically designed 
to be complementary to the conserved regions located 
at the beginning of genes (approximately 540  bp). The 
resulting amplified 16S rDNA sequences allow for ade-
quate differentiation of bacteria with a sufficiently high 
rate of detection, thereby establishing a reliable basis for 
in silico analyses for identification by 16S rDNA gene 
sequencing (Clarridge 2004). Thus, investigation of clini-
cal samples using this methodology represents a cultiva-
tion-independent alternative approach for the detection 
of nonviable bacteria and bacteria with fastidious growth 
requirements in various clinical samples.
Healthcare-associated infections (HCAIs) result 
in mortality, morbidity, and increased healthcare 
costs worldwide (Labelle et  al. 2010). Microbiological 
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identification of the causative organism is well recog-
nised to be crucial in the treatment of HCAIs (Saito et al. 
2012). Some reports have indicated that the administra-
tion of empirical antibiotic therapy prior to microbiologi-
cal diagnosis is associated with the failure of subsequent 
bacterial growth in culture. Additionally, negative cul-
ture results in the microbiological diagnosis of hospi-
tal-acquired infections (HAIs) have been attributed to 
several factors, including inadequate sample collection 
and the time elapsed between sample collection and 
analysis (Nikkari et  al. 2002; Bhattacharya and Mondal 
2010). In these particular cases, molecular diagnosis can 
be quite useful. For example, this approach has been par-
ticularly valuable for the diagnoses of brain abscess, aor-
tic infection, bacteraemia, pneumonia and liver abscess 
and prosthetic joint infections (Kommedal et  al. 2009, 
Labelle et  al. 2010; Saito et  al. 2012; Hartley and Harris 
2014). The aim of this paper was to perform a prelimi-
nary study to determine whether this approach of broad-
range bacterial 16S rDNA PCR and direct sequencing is 
particularly valuable for implementation and to identify 
key diagnostic findings to improve the diagnosis of infec-
tions in hospital laboratories.
Methods
Sample collection and ethical statement
Over a period of 3  months, 300 culture-negative speci-
mens from different anatomic sites were collected at the 
Laboratory of Special Tests at the National Medical Cen-
tre (Centro Médico Nacional (CMN) 20 de Noviembre) 
of the Institute of Security and Social Services for State 
Workers (Instituto de Seguridad y Servicios Sociales de 
los Trabajadores del Estado, ISSSTE) in Mexico City. 
Once the clinical laboratory reported that samples were 
negative by culture (and before properly discarding the 
samples as biowaste), 1 mL of each sample was placed in 
a 1.5-mL tube for DNA extraction for use in the present 
study. In accordance with all applicable federal regula-
tions concerning the protection of human subjects (Gen-
eral Health Low, Title Two, Articles 17 and 23), acquiring 
informed consent from patients is not mandatory for safe 
research (when no risk is imposed upon the patients). 
This study was classified as safe research because all 
cultures were ordered by physicians due to the neces-
sity of clinical management, and any samples specifi-
cally collected for this study, in addition to the datasets, 
were de-identified. The ethics committee “CMN 20 de 
Noviembre” reviewed and approved the protocol (num-
ber 014-2012).
Negative culture sample definition
Samples were included in the present study present-
ing any evidence of bacterial infection other than that 
observed by clinical examination. Samples were deemed 
culture negative if any aetiologic agents were recovered 
for 7 days at 37 °C using the standard microbiology lab-
oratory procedures. The samples were analysed for the 
presence of bacteria and fungi.
DNA extraction from specimens
DNA extraction was performed using a High Pure PCR 
Template Preparation Kit (Roche Diagnostics, Indian-
apolis, IN) according to the manufacturer’s instructions. 
Briefly, 200  µL of sample was incubated at 76  °C with 
Binding Buffer provided by the kit and proteinase K, fol-
lowed by washes with isopropanol, an inhibitor removal 
solution and washing buffer. Finally, the DNA was eluted 
and stored at −20 °C until use.
16S rDNA amplification
Broad-range PCR targeting the 16S rDNA gene V1-V3 
variable regions was performed as previously described 
(Kommedal et  al. 2009), with certain modifications as 
stated below. PCR amplification was performed in a final 
volume of 25  µL, containing the DNA sample, 1X PCR 
buffer (Invitrogen™, Carlsbad, CA), 2.5 U Taq DNA 
recombinant polymerase (Invitrogen™, Carlsbad, CA), 
0.25 mM deoxynucleotide triphosphate (dNTP) mix (Inv-
itrogen™, Carlsbad, CA), 0.1 µM of each primer (forward 
primer 5′ TTG-GAG-AGT-TTG-ATC-MTG-GCT-C 3′ 
and reverse primer 5′ GTA-TTA-CCG-CGG-CTG-CTG 
3′) and 1 mM MgCl2; 0.6 % bovine serum albumin (BSA) 
was added to prevent PCR inhibition. All reactions were 
performed with a T-Gradient Thermoblock PCR System 
(Biometra, Goettingen, Germany). The cycling condi-
tions used to amplify the ~510  bp product consisted of 
initial denaturation at 94 °C for 5 min, 30 cycles of melt-
ing at 94 °C for 30 s, annealing at 53.2 °C for 1 min, and 
elongation 72 °C for 1 min, and a final extension step at 
72 °C for 5 min. To verify the presence of the amplifica-
tion products, 5  µL of each PCR-amplified sample was 
separated by electrophoresis on a 1.0  % agarose gel. A 
100-bp DNA molecular marker was included in some 
of the electrophoresis runs (Invitrogen™, Carlsbad, CA). 
The remaining 20 µL of sample was frozen for later use. 
Each sample was run in parallel with a negative control 
(with addition of distilled water instead of DNA) and a 
positive control (with addition of DNA from a positive 
sample that had been previously tested).
Sequencing and identification
A phylogenetic tree was constructed to show the rela-
tionships of the sequences identified by sequence 
analysis. The PCR products were cleaned using a Mon-
tage Gel Extraction Kit (Concord Road, Billerica, MA) 
according to the manufacturer’s instructions and were 
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authenticated via DNA sequencing with an ABI-PRISM™ 
310 system (Applied Biosystems, Foster City, CA) accord-
ing to the manufacturer’s recommendations.
Initially, DNA sequences amplified using the for-
ward and reverse primers were assembled. The obtained 
sequences (n  =  19) were edited to exclude the PCR 
primer-binding sites, and ambiguous and incorrectly 
called bases were manually corrected using BioEdit ver-
sion 7.0.9.0 (Hall 1999), CLUSTAL_X (Larkin et  al. 
2007) and Seaview version 4.3.3 (Gouy et  al. 2010). All 
sequences were compared to those available for the 
V1-V3 regions of the 16S rDNA gene in GenBank DNA 
databases (nr/nt and refseq_rna) using the BLAST algo-
rithm (www.ncbi.nih.gov) (Morgulis et  al. 2008). Multi-
ple sequence alignments were performed using Clustal X 
version 2.0 (Larkin et al. 2007), and the alignments were 
edited with SeaView (Galtier et  al. 1996). The analyses 
were performed using the default setting parameters in 
all the software’s. The identities of the sequences of genus 
and species was presumed to be correct for clinical sam-
ples if sequence identities was of 97 and 99  %, respec-
tively to reference sequences of strains match in GenBank 
and EZTaxon databases (Kim et al. 2012; Morgulis et al. 
2008; Stackebrandt and Ebers 2006; Rosselló-Mora and 
Amann 2001). A phylogenetic tree was constructed for 
each sequence using the maximum parsimony method 
(MP) and neighbour-joining (NJ), in the NJ method the 
substitution model of Tamura–Nei was used. Phyloge-
netic analyses were conducted using Mega 6 (Tamura 
and Nei 1993; Tamura et al. 2013). The stability or accu-
racy of each inferred topology was assessed by bootstrap 
analysis with 1000 replicates (data not shown). Finally, 
using the consensus sequences of assigned identification, 
a general NJ tree was constructed using the substitution 
model of Tamura–Nei and Mega 6 software (Tamura and 
Nei 1993; Tamura et al. 2013). The stability or accuracy of 
each inferred topology was assessed by bootstrap analysis 
with 1000 replicates. The sequences included were inten-
tionally selected from the GenBank database in order to 
highlight the species identification. Their accession num-
bers are listed in brackets (Fig. 1).
Mixed DNA chromatograms were analysed using the 
RipSeq web application (iSentio). The RipSeq mixed 
algorithm searches against the “16S human pathogen 
iSentio” database (Kommedal et al. 2009). The sequences 
obtained herein were submitted to the GenBank database 
under the accession numbers KJ437454 to KJ437472.
Epidemiological information
To confirm the HAIs, the official Mexican standard 
NOM-045-SSA2-2005 criteria were used. The main clini-
cal criteria for defining an HAI include fever, positive 
urinary culture, positive chest X-ray radiography results, 
symptoms observed on physical examination by a pul-
monologist, positive phlegm and blood cultures, leuco-
cytosis detection and evidence of an HAI in other bodily 
discharges. The data were collected using a checklist by 
the observer of the sample collection and were recorded 
in a series of clinical data documents. The patient micro-
biological information was collected and checked with 
respect to the date of admission, date of specimen cul-
ture, and culture results. The patients were visited by 
an infectious disease specialist, and all clinical manifes-
tations of the patients were noted in the checklist. Ini-
tially, all 300 samples were considered positive for HAIs 
because they were obtained from patients who had been 
hospitalised for at least 48 h, and they were all collected 
because of clinically suspected infections.
Results
This study included 300 culture-negative samples. Broad-
range 16S rDNA PCR showed positive results for 23 of 
these samples, demonstrating the presence of bacterial 
DNA. The relevant characteristics of the 23 positive cases 
are listed in Table 1. The sequences of 19 of the 23 ampli-
cons were identified by rDNA analysis; 11 different gen-
era were detected and identified using this methodology. 
Four mixed infections were detected by PCR, although 
identification using RipSeq Mixed software was not per-
formed due to the low quality of the sequencing chroma-
tograms. After clinical history revision, 15 of the 23 cases 
were defined as HAIs. Among the other 8 cases, 6 and 2 
were classified as catheter colonisation and sample con-
tamination, respectively (Table 1).
Sufficient clinical evidence of an HAI and recognised 
infectious pathogens were detected in 9 of the 15 HAIs, 
including Pseudomonas (n  =  2), Enterococcus (n  =  3), 
Escherichia (n =  2), Staphylococcus (n =  1) and Salmo-
nella (n  =  1). The less common agents were Agrococ-
cus sp., Bacillus sp. and Achromobacter sp. were also 
detected (3 cases). Mixed infection was detected in the 
other 3 cases, for which the aetiological agent could not 
be identified due to low sequence quality.
No evidence of infection was found in the medical 
records in the samples were coagulase-negative staphy-
lococci (CoNS) (n  =  3), Kocuria (n  =  1), Leuconostoc 
(n = 1) and Enterococcus (n = 1) as tip or catheter colon-
isers. Leuconostoc was identified, probably as a contami-
nant of that particular sample as a result of poor sample 
management.
Although bacteraemia and urinary tract infection 
(UTI) were the most frequent infections, meningi-
tis, warm infection and soft tissue infection were also 
documented.
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Bacteria identified to the species level by broad-range 
16S rDNA PCR and sequencing from 19 samples with 
negative culture is show in the Fig. 1.
Discussion
The accurate identification of bacterial isolates is one 
of the most important goals of a microbiology labora-
tory; such identification allows for the establishment of 
an effective antibiotic therapy as well as procedures that 
must be implemented to control the spreading of infec-
tion. Nevertheless, in the case of HCAIs, this step can 
be complicated due to several factors that affect culture 
sensitivity, such as adequate sample collection, the type 
of bacteria to be cultivated, and most importantly, the 
use of broad-spectrum antibiotics prior to sample collec-
tion (Nikkari et al. 2002; Bhattacharya and Mondal 2010; 
Rampini et al. 2011).
Due to the limitations of culturing, molecular tech-
niques have been implemented in recent years for the 
detection and identification of bacterial pathogens. Gene 
amplification followed by sequencing is a promising diag-
nostic method, not only for pathogen identification but 
Fig. 1 Bacteria identification to the species level by broad‑range 16S rDNA PCR and sequencing from 19 samples with negative culture. This general 
tree was generated using the neighbour‑joining (NJ) with the Tamura–Nei model. The numbers shown at the branch point indicate bootstrap val‑
ues. The dataset was subjected to 1000 bootstrap replications. The sequences were selected from the GenBank database, and their accession num‑
bers are listed in brackets. Sequences with an asterisk correspond with the clinical samples from this study, and the sequence accession numbers are 
GenBank KJ437454 to KJ437472. All the sequences could be an assign unambiguously to a genus. The species designation was determining with 
the closest genetic identification based on GenBank sequence analysis
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also for the discovery of unknown or “difficult to grow” 
microorganisms (Harris and Hartley 2003; Petti 2007). In 
our study, sixteen of the 23 positive patients had received 
broad-range antibiotic therapy with single or multiple 
antibiotics for long durations before the samples were 
collected, which could explain why the samples identified 
as positive by direct amplification and sequencing were 
culture negative (Additional file 1: Table S1).
Clinicians are frequently challenged by the suspicion 
of acute infectious disease, even when a conventional 
microbiological culture remains negative (Nikkari et  al. 
2002; Kommedal et  al. 2009; Rampini et  al. 2011). In 
the present study, this issue occurred in fifteen samples 
from patients clinically diagnosed with an HAI who had 
negative culture results. Overall, direct broad-range PCR 
amplification and sequencing, which can be used to iden-
tify recognised aetiological HAI agents, is a suitable sup-
plemental method for the diagnosis of infections (Hartley 
and Harris 2014).
A retrospective medical record review showed that 
many samples submitted for microbiological analysis 
were obtained from patients without definitive evidence 
of an HAI. This issue has been previously reported by 
Rampini et al. (2011) and has been attributed to the dif-
ficulty of accurately diagnosing infections at the bed-
side. However, when laboratory findings (from 16S gene 
analyses) were considered in addition to clinical exami-
nation results in this study, at least 2 samples that were 
not previously clinically identified as HAIs were reclas-
sified as HAIs, 2 additional samples were considered to 
contain contaminants, and 6 were considered to have 
catheter or tip colonisation. This finding highlights the 
utility of culture-independent identification as a com-
plementary method for troubleshooting clinical speci-
mens to support a clinical diagnosis. A quantitative study 
should be performed in the future because in almost all 
samples, except for those with catheter tip colonisation, 
the microbial load was critical for the clinical diagnosis 
Table 1 Relevant characteristics of the positive broad-range PCR samples
CSF cerebrospinal fluid; ICU-A intensive care unit, adult; ICU-N intensive care unit, new‑born; BU burn unit; PIM paediatric internal medicine; MMF maternal foetal 
medicine; ICU-P intensive care unit, paediatric; UTI urinary tract infection; PI paediatric infectology; STI soft tissue infection; HCAI clinical healthcare infection; UD the 
outcome was not known at the time of the study
a The species designation was determining with the closest genetic identification based on GenBank sequence analysis (Fig. 1)
b Aetiological agents of polybacterial infections could not be identified due to low‑quality sequences
Case number Sample type 16S rRNA identificationa Hospital area HAI Symptomatology of HAI Outcome
002‑001 Bronchial aspirate Mixed infectionb ICU‑A Undemonstrated bacte‑
raemia
Yes Improvement
002‑005 CSF Agrococcus sp. ICU‑N Meningitis Yes UD
002‑011 Blood culture Mixed infectionb BU Undemonstrated bacte‑
raemia
Yes Improvement
002‑085 Blood culture Pseudomonas sp. Haematology Bacteraemia Yes Death
002‑088 Blood culture Mixed infectionb Haematology Sample contamination Yes Death
002‑095 Blood culture Bacillus sp. Haematology Bacteraemia Yes UD
002‑114 Blood culture Mixed infectionb Haematology Bacteraemia Yes UD
002‑174 Blood culture Leuconostoc sp. Haematology Sample contamination Yes Improvement
002‑028 Catheter tip Staphylococcus sp. BU Catheter colonisation Yes Improvement
002‑029 Catheter tip Staphylococcus sp. Cardiology Catheter colonisation Yes Improvement
002‑038 Catheter tip Staphylococcus sp. Cardiology Catheter colonisation Yes Death
002‑039 Catheter tip Kocuria sp. Haematology Catheter colonisation Yes Improvement
002‑167 Catheter tip Enterococcus sp. PIM Catheter colonisation Yes Transfer
002‑169 Catheter tip Enterococcus sp. Haematology Bacteraemia Yes UD
002‑023 Urine Pseudomonas sp. ICU‑A UTI Yes Death
002‑065 Urine Achromobacter sp. Haematology UTI Yes Death
002‑103 Urine Pseudocitrobacter sp. ICU‑A Catheter colonisation Yes Death
002‑104 Urine Escherichia sp. ICU‑A UTI Yes Improvement
002‑105 Urine Enterococcus sp. Neurology UTI Yes Transfer
002‑106 Urine Escherichia sp. MMF UTI Yes UD
002‑170 Ulcer Salmonella sp. PI Wound Yes UD
002‑037 Wound secretion Staphylococcus sp. UTIP STI Yes Death
002‑171 Wound secretion Enterococcus sp. Rheumatology Wound Yes Transfer
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of infections originating from the bacteria identified by 
molecular analysis. Among the analysed samples, the 
proposed analysis could be interesting for the testing of 
bronchial aspirates an additional diagnostic method; 
however, in some of the samples, the positive result was 
almost certainly due to a contaminant or pathogen with a 
non-significant bacterial load.
Some of the detected bacteria (CoNS and Kocuria sp.) 
are part of the normal skin microbiota. It is important to 
determine whether the isolation of these bacteria rep-
resents true infection or colonisation. The latter is quite 
common during specimen collection in patients with a 
long hospital stay. CoNS have emerged as predominant 
pathogens in HAIs and are recognised as the most com-
mon causes of bloodstream infection (BSI). Infection 
with CoNS is usually related to the use of intravascu-
lar devices, such as central venous catheters, peripheral 
venous catheters, haemodialysis catheters, and prosthetic 
materials. In this study, 4 cases of CoNS infection were 
found, 3 and one of which were associated with cath-
eter tip colonisation and wound infection, respectively. 
In three cases, Staphylococcus closest to S. warneri was 
identified as a coloniser, and in one case, Staphylococ-
cus closest to S: capitis was identified. Although this 
particular case was not considered an HAI because the 
patient did not present with signs of infection and given 
that Kocuria has been related to catheter-associated BSIs, 
the opportune detection of catheter colonisation by this 
bacterium is important for preventing the development 
of bacteraemia. The clinical significance of species other 
than S. epidermidis has been increasingly recognised in 
recent years; however, these species are rarely isolated. 
Nevertheless, S. capitis was detected in a wound secre-
tion sample from a patient with an HAI. Given the ability 
of Staphylococcus closest to S. capitis to establish wound 
infections (associated biofilm-embedded bacteria) and 
because all clinical criteria were present in the infected 
patient, it is clear that this species was an aetiological 
agent of the infection, thereby indicating an HAI (Senger 
et al. 2007). On the other hand, Staphylococcus closest to 
S. warneri was isolated from catheter tips of patients with 
underlying immunosuppressive conditions, although 
peripheral blood cultures were not positive; in these 
cases, this bacterium was considered as having colonised 
the catheter or tip.
Kocuria sp. was detected in a 45-year-old male with 
acute lymphocytic leukaemia after 3  months evolution 
of the disease and who had been hospitalised for 3 days 
at the Haematology Service. Some Kocuria species have 
been associated with different HCAIs, including abscess 
and catheter-associated blood stream infection, and 
some authors have claimed that it is imperative to per-
form genetic analyses of Kocuria species because they 
are emerging pathogens (Lai et al. 2011; Tsai et al. 2010). 
Although this particular case was not considered an HAI 
because the patient did not present with signs of infec-
tion and given that Kocuria has been related to cathe-
ter-associated BSIs, the opportune detection of catheter 
colonisation by this bacterium is important for prevent-
ing the development of bacteraemia.
To date, Agrococcus lahaulensis and B. galliciensis 
have been described as environmental inhabitants, and 
there are no previous reports of their possible roles as 
aetiological agents of HAIs. In this study, these two spe-
cies were considered aetiological agents because the 
new-borns from which they were isolated had the clini-
cal criteria for meningitis and bacteraemia, respectively. 
Notably, even though these patients were bacterial and 
fungal culture negative, they could have had enterovirus 
infections; however, this issue was not examined, and 
this hypothesis could not be tested. Other Bacillus spe-
cies can cause serious infections in immunosuppressed 
patients and are frequently associated with HCAIs in 
neonatal intensive care units. Agrococcus lahaulensis is 
an actinobacterium belonging to the family Microbac-
teriaceae. Certain actinobacteria are currently classified 
as hazardous biological agents in the workplace because 
actinobacteria have been increasingly detected in work-
places such as composting facilities, agricultural settings, 
waste management facilities, libraries and museums 
(Coenye et al. 2003).
These issues emphasise the need for an interdiscipli-
nary approach to analyses of cases of nosocomial infec-
tion to avoid sample contamination and to determine 
whether a microorganism should be considered an aetio-
logical agent (Rampini et al. 2011; Cuervo et al. 2008).
Achromobacter insolitus is an unusual or uncom-
mon organism found only rarely in human clinical sam-
ples. The type strain LMG 6003T was isolated from a 
leg wound. To our knowledge, it is the first case of an 
HAI caused by this bacterium that has been reported 
in Mexico. However, because the pathogenic potential 
of Achromobacter insolitus has not been demonstrated, 
classification of this case as an HAI should be carefully 
considered and thoroughly investigated in the future.
Leuconostoc spp. are lactic acid bacteria that inhabit 
the skin, and they are commonly considered to be sample 
contaminants. Nevertheless, in patients with an under-
lying illness, Leuconostoc spp. could cause bacteraemia, 
and the number of reports of bacteraemia caused by this 
microorganism associated with the use of intravenous 
catheters is increasing (Cuervo et  al. 2008; Bou et  al. 
2008).
The RipSeq algorithm has been validated for use with 
samples containing up to three different species of bac-
teria, although four bacterial species can occasionally be 
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identified (Kommedal et  al. 2009). Therefore, this soft-
ware was applied to analyse four samples (one bronchial 
aspirate and three blood cultures). However, the result-
ing chromatograms were so complex that all of the peaks 
could not be included without exceeding the limitation of 
the RipSeq algorithm. Therefore, the obtained identifica-
tions were not dependable. Previous studies have shown 
that competition for reagents in mixed samples repre-
sents a major challenge in the performing of broad-range 
PCR and DNA sequencing directly from polybacterial 
samples (Kommedal et al. 2009). To minimise this prob-
lem, the use of Gram type-specific broad-range primers 
and the amplification of Gram-positive and Gram-neg-
ative bacteria in different tubes could be an alternative 
approach (Kommedal et al. 2011).
Other strategies to avoid these problems include the 
use of cloning and high-throughput pyrosequencing or 
denaturing gradient gel electrophoresis (DGGE) followed 
by DNA sequencing of the different fragments. Unfortu-
nately, these diagnostic methods are even more complex, 
costly, labour-intensive and technically challenging than 
broad-range PCR and direct sequencing. In addition, 
these methods are associated with shortcomings with 
respect to the detection of minor populations in samples 
with large differences in the relative concentrations of the 
different bacterial constituents. Therefore, the next step 
in the resolution of polymicrobial samples is using high-
throughput next generation sequencing of 16S rDNA 
amplicons (Hartley and Harris 2014).
The main disadvantage of molecular diagnosis is that 
antimicrobial susceptibility cannot be determined. How-
ever, this study has provided sufficient information for 
the elucidation of molecular antimicrobial susceptibility 
in the near future.
In this study the variable regions V1, V2 and V3 of the 
16S rDNA gene was used (≈500  bp). All the sequences 
could be an assign unambiguously to a genus. The species 
name were determine when 98–100 % similarity to more 
than one GenBank sequence of the same species and/or 
tight clustering with members of one species (Fig. 1). A 
second bioinformatics analysis was performed in curated 
EzTaxon database to in order to confirm the sequences 
identification, with both methods accurate results were 
obtain.
Conclusions
Our findings support the importance of the use of molec-
ular methods as a supplemental routine method for 
direct bacterial identification when troubleshooting clini-
cal specimens. The results of broad-range PCR and direct 
sequencing should be analysed in parallel with clinical 
data to determine whether the identified bacterium has 
medical importance or is a sample contaminant.
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